PD-L2 Is Constitutively Expressed in Normal and Malignant Urothelium
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.626748
Abstract: The use of immune checkpoint blockade, in particular PD-1 and PD-L1 inhibitors, is now commonplace in many clinical settings including the treatment of muscle-invasive bladder cancer (MIBC). Notwithstanding, little information exists regarding the expression of… read more here.
Keywords: expressed normal; normal malignant; malignant urothelium; expression ... See more keywords